{"id":"6b856670-c7aa-4a36-902c-142de2328a86","short_name":"grl","human_readable_name":"Genome Research Limited","dataset_count":2,"created_date":"2025-12-01T11:38:00+00:00","data_portal_url":"","default_licence_id":"uk-ogl","description":"The Institute and the wider Wellcome Genome Campus operate under the name of Genome Research Limited (GRL). GRL was established in 1992 and is a wholly owned subsidiary of the Wellcome Trust. In 2012, the Wellcome Trust Board of Governors agreed to place all activities on the Wellcome Genome Campus, including the Sanger Institute, under the auspices of GRL in order to facilitate the development of a long term and coherent strategy for the Campus and all activities on it.\n\nThrough the activities of the Wellcome Sanger Institute and the wider Genome Campus, the ambition of GRL over the next 20 years is to strengthen its well-established scientific foundations and to build on them, such that the Wellcome Genome Campus becomes an international centre for scientific, business, cultural and educational activities emanating from Genomes and BioData. To achieve this vision GRL’s Mission is to:\n\nAdvance understanding of biology using genome sequences and biodata.\nApply genome science for human health and other societal benefits.\nFoster discussion of the scientific, medical and wider implications of genomes.","exclusions_policy_url":"","first_publication_date":"2023-07-06T15:10:00+00:00","hq_country":"GB","organisation_identifier":"GB-COH-02742969","organisation_type":"80","region":"","reporting_source_type":"primary_source","website":""}